FindTrial
Sign In

IMMUNO - MODULATORY EFFECT OF HINGULA BHASMA

Screening of free radical scavenging activity and immuno - modulatory effect of hingula bhasma an experimental study. - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080839
Enrollment
5
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr.Nikita Pandey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy subject

Exclusion criteria

Exclusion criteria: 1) Metabolic disorders like Diabetic Mellitus, hypertension, immune disorders etc. 2) Subjects in the convalescent phase of any infection. 3) Subjects who are on any medications within the duration of 2 to 3 months.

Design outcomes

Primary

MeasureTime frame
Provides part of molecular evidence on mode of action of hingul bhasmaTimepoint: 72 week—

Secondary

MeasureTime frame
NILLTimepoint: NILL—

Countries

India

Contacts

Public ContactDr P G Jadar

KLE Academy of Higher Education & Research Deemed to be University

drjadar@yahoo.co.in9448301308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026